Followers | 3819 |
Posts | 240201 |
Boards Moderated | 0 |
Alias Born | 07/30/2007 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 22, 2014 8:21:41 PM
## source: finance.yahoo.com
Tue, 14 Oct 2014 16:00:00 GMT ~ Ebola Could Offer Significant Opportunity for AEMD
read full: http://finance.yahoo.com/news/ebola-could-offer-significant-opportunity-160000258.html
*********************************************************
Tue, 14 Oct 2014 13:28:04 GMT ~ Aethlon Medical's OTC shares surge on use of device in Ebola treatment
read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=57039E39-ADA4-4B85-B13F-5E5C55EEE409&siteid=yhoof2
*********************************************************
Tue, 14 Oct 2014 11:15:00 GMT ~ Aethlon Medical Announces First Treatment of an Ebola Patient
[PR Newswire] - SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), announced today the first use of Hemopurifier® therapy on a patient infected with Ebola virus. The treatment was administered to a Ugandan doctor at the Frankfurt University Hospital in Germany. The patient, who is also a World Health Organization (WHO) worker, contracted the virus in Sierra Leone. The Aethlon Hemopurifier® is a first-in-class bio-filtration device that targets the rapid elimination of viruses and immunosuppressive proteins from the circulatory system of infected individuals. At present, no antiviral therapy or vaccine has proven to be effective against Ebola virus infection in humans. The largest ebola virus epidemic in history is now spreading on a global basis with more than 4,000 deaths being reported by the WHO.
read full: http://finance.yahoo.com/news/aethlon-medical-announces-first-treatment-111500188.html
*********************************************************
Tue, 07 Oct 2014 13:00:00 GMT ~ SeeThruEquity Issues Company Note on Aethlon Medical and Increase Target Price to $0.52
[Accesswire] - Company Announces Collaboration with Boston University CTE Center and Expanded Hemopurifier Clinical Studies New York, NY / ACCESSWIRE / October 7, 2014 / SeeThruEquity, a leading independent equity research ...
read full: http://finance.yahoo.com/news/seethruequity-issues-company-note-aethlon-130000594.html
*********************************************************
Tue, 07 Oct 2014 12:30:00 GMT ~ Aethlon Medical, Inc. – “A Pivotal Moment That Changed the NFL and CTE Research”
[Accesswire] - New York, NY / October 7, 2014 / Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD) today published a new blog post on The Chairman’s Blog, written by the Company’s Chairman and CEO, James Joyce. TheChairmansBlog.com ...
read full: http://finance.yahoo.com/news/aethlon-medical-inc-pivotal-moment-123000375.html
*********************************************************
$AEMD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AEMD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AEMD/company-info
Ticker: $AEMD
OTC Market Place: OTCQB
CIK code: 0000882291
Company name: Aethlon Medical, Inc.
Company website: http://www.aethlonmedical.com
Incorporated In: NV, USA
Business Description: The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non-government research organizations, the Hemopurifier is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats.Less >>
$AEMD share structure
## source: otcmarkets.com
Market Value: $53,524,821 a/o Oct 21, 2014
Shares Outstanding: 261,096,690 a/o Aug 12, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$AEMD extra dd links
Company name: Aethlon Medical, Inc.
Company website: http://www.aethlonmedical.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AEMD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AEMD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AEMD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AEMD/news - http://finance.yahoo.com/q/h?s=AEMD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AEMD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AEMD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AEMD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AEMD
DTCC (dtcc.com): http://search2.dtcc.com/?q=Aethlon+Medical%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Aethlon+Medical%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Aethlon+Medical%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.aethlonmedical.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.aethlonmedical.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.aethlonmedical.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AEMD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000882291&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AEMD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AEMD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AEMD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AEMD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AEMD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AEMD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AEMD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AEMD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AEMD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AEMD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AEMD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AEMD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AEMD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AEMD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AEMD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AEMD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AEMD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AEMD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AEMD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AEMD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AEMD
$AEMD ~ Aethlon Medical, Inc.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM